.RESEARCH STUDY FEATURE.06 August 2024.
A big randomized controlled trial with cisgender girls highlights the obstacles of adherence to a daily dental preexposure prevention program and also demonstrates that twice-yearly injection of lenacapavir can keep successful HIV avoidance degrees over 6 months.